150 related articles for article (PubMed ID: 7660719)
21. Leuprolide and estrogen versus oral contraceptive pills for the treatment of hirsutism: a prospective randomized study.
Azziz R; Ochoa TM; Bradley EL; Potter HD; Boots LR
J Clin Endocrinol Metab; 1995 Dec; 80(12):3406-11. PubMed ID: 8530573
[TBL] [Abstract][Full Text] [Related]
22. An open randomized comparative study of an oral contraceptive containing ethinyl estradiol and cyproterone acetate with and without the GnRH analogue goserelin in the long-term treatment of hirsutism.
Vegetti W; Testa G; Maggioni P; Motta T; Falsetti L; Crosignani PG
Gynecol Obstet Invest; 1996; 41(4):260-8. PubMed ID: 8793497
[TBL] [Abstract][Full Text] [Related]
23. Treatment of severe hirsutism resulting from hyperandrogenism with the reverse sequential cyproterone acetate regimen.
Garner PR; Poznanski N
J Reprod Med; 1984 Apr; 29(4):232-6. PubMed ID: 6232380
[TBL] [Abstract][Full Text] [Related]
24. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
Kazerooni T; Dehghan-Kooshkghazi M
Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
[TBL] [Abstract][Full Text] [Related]
25. Determining the time androgens and sex hormone-binding globulin take to return to baseline after discontinuation of oral contraceptives in women with polycystic ovary syndrome: a prospective study.
Sánchez LA; Pérez M; Centeno I; David M; Kahi D; Gutierrez E
Fertil Steril; 2007 Mar; 87(3):712-4. PubMed ID: 17118366
[TBL] [Abstract][Full Text] [Related]
26. Combined use of metformin and ethinyl estradiol-cyproterone acetate in polycystic ovary syndrome.
Mitkov M; Pehlivanov B; Terzieva D
Eur J Obstet Gynecol Reprod Biol; 2005 Feb; 118(2):209-13. PubMed ID: 15653205
[TBL] [Abstract][Full Text] [Related]
27. Polycystic ovary syndrome in bulimic women--an evaluation based on the new diagnostic criteria.
Naessén S; Carlström K; Garoff L; Glant R; Hirschberg AL
Gynecol Endocrinol; 2006 Jul; 22(7):388-94. PubMed ID: 16864149
[TBL] [Abstract][Full Text] [Related]
28. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.
Doldi N; Persico P; Di Sebastiano F; Marsiglio E; Ferrari A
Gynecol Endocrinol; 2006 May; 22(5):235-8. PubMed ID: 16785142
[TBL] [Abstract][Full Text] [Related]
29. Hirsutism and polycystic ovary syndrome.
Givens JR; Goodman RC
Hosp Pract (Off Ed); 1986 Oct; 21(10A):81-4, 87-9, 93-4 passim. PubMed ID: 3095345
[No Abstract] [Full Text] [Related]
30. Gonadotropin-releasing hormone analogue plus hormone replacement therapy for the treatment of endometriosis: a randomized controlled trial.
Gregoriou O; Konidaris S; Vitoratos N; Papadias C; Papoulias I; Chryssicopoulos A
Int J Fertil Womens Med; 1997; 42(6):406-11. PubMed ID: 9459084
[TBL] [Abstract][Full Text] [Related]
31. 17-Hydroxysteroid dehydrogenase type 5 gene polymorphism (-71A/G HSD17B5 SNP) and treatment with oral contraceptive pills in PCOS women without metabolic comorbidities.
Maier PS; Mattiello SS; Lages L; Spritzer PM
Gynecol Endocrinol; 2012 Aug; 28(8):606-10. PubMed ID: 22329763
[TBL] [Abstract][Full Text] [Related]
32. Effects of an oral contraceptive containing cyproterone acetate (Diane-35) on the symptoms, hormone profile, and ovarian volume of hirsute women with polycystic ovarian syndrome.
Prelević GM; Puzigaća Z; Balint-Perić LA
Ann N Y Acad Sci; 1993 May; 687():255-62. PubMed ID: 8323181
[No Abstract] [Full Text] [Related]
33. Influence of body mass index on measured and calculated androgen parameters in adult women with Hirsutism and PCOS.
Cupisti S; Dittrich R; Binder H; Kajaia N; Hoffmann I; Maltaris T; Beckmann MW; Mueller A
Exp Clin Endocrinol Diabetes; 2007 Jun; 115(6):380-6. PubMed ID: 17701884
[TBL] [Abstract][Full Text] [Related]
34. Differential suppression of testosterone and estradiol in hirsute women with the superactive gonadotropin-releasing hormone agonist leuprolide.
Rittmaster RS
J Clin Endocrinol Metab; 1988 Oct; 67(4):651-5. PubMed ID: 3138274
[TBL] [Abstract][Full Text] [Related]
35. Comparison of a gonadotropin-releasing hormone agonist and a low dose oral contraceptive given alone or together in the treatment of hirsutism.
Heiner JS; Greendale GA; Kawakami AK; Lapolt PS; Fisher M; Young D; Judd HL
J Clin Endocrinol Metab; 1995 Dec; 80(12):3412-8. PubMed ID: 8530574
[TBL] [Abstract][Full Text] [Related]
36. Clinical and endocrine effects of flutamide in hyperandrogenic women.
Fruzzetti F; De Lorenzo D; Ricci C; Fioretti P
Fertil Steril; 1993 Nov; 60(5):806-13. PubMed ID: 8224265
[TBL] [Abstract][Full Text] [Related]
37. Treatment of hirsutism with a gonadotropin-releasing hormone agonist and estrogen replacement therapy.
Morcos RN; Abdul-Malak ME; Shikora E
Fertil Steril; 1994 Mar; 61(3):427-31. PubMed ID: 8137961
[TBL] [Abstract][Full Text] [Related]
38. Obesity affects circulating estradiol levels of premenopausal hirsute women receiving leuprolide acetate depot.
Dumesic DA; Matteri RL
Int J Fertil Menopausal Stud; 1993; 38(3):139-46. PubMed ID: 8348161
[TBL] [Abstract][Full Text] [Related]
39. Effects of a low-dose desogestrel-ethinylestradiol combination on hirsutism, androgens and sex hormone binding globulin in women with a polycystic ovary syndrome.
Cullberg G; Hamberger L; Mattsson LA; Mobacken H; Samsioe G
Acta Obstet Gynecol Scand; 1985; 64(3):195-202. PubMed ID: 3160211
[TBL] [Abstract][Full Text] [Related]
40. [Clinical use of antiandrogens in the female].
Moltz L; Schwartz U; Hammerstein J
Gynakologe; 1980 Mar; 13(1):1-17. PubMed ID: 6299908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
